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Abstract 
A randomized experimental design was used to assign participants to an integrated mental health 
and substance use treatment program or to standard hospital treatment. A multilevel, nonlinear 
model was used to estimate hospital treatment effects on days of alcohol use for persons with serious 
mental illness and substance use disorders over 18 months. The integrated treatment program had a 
significant effect on the rate of alcohol use at 2 months postdischarge, reducing the rate of  use by 
54%. Motivation for sobriety at hospital discharge, posttreatment self-help attendance, and social 
support for  sobriety were also found to reduce the rate of  use during the follow-up period Implica- 
tions for mental health treatment and aftercare support are discussed. 
Program models  for treating persons with serious mental illness and substance use disorders 
(SMI-SD)  generally involve hybrid or integrated services)  "3 These programs emphasize the need to 
recognize stages of treatment and the importance of  persuasion and engagement.  3"6 Studies of  the 
effectiveness of integrated inpatient programs have indicated mixed results. Some studies have 
f o u n d  i m p r o v e d  c o m m u n i t y  f u n c t i o n i n g :  "~3 Yet, o the r s  have  been  unab l e  to i d e n t i f y  
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posthospitalization treatment effects) ~-17 A review by Drake et al)8 of 36 studies of  the effectiveness 
of integrated treatment programs, including inpatient intensive integrated treatment and comprehen- 
sive integrated dual disorder treatment, noted mixed results from many of these studies but con- 
cluded that there is encouraging evidence that these programs do engage persons with SMI-SD and 
help them reduce their substance use. This review also points out that outcomes related to 
posttreatment hospital use, psychiatric symptoms, and other domains are less consistent. 
A number of  these studies have looked for direct effects of SMI-SD treatment on later psychiatric 
and substance use outcomes. These studies have not, however, explicitly modeled the effects of 
proximal or suboutcomes of treatment (e.g., changes in motivation, attitudes, behaviors) ~9 on longi- 
tudinal substance use and functioning. Several authors have emphasized the need for after-care ser- 
vices following hospitalization '7':e'2~ and have examined the longitudinal effects of treatment. They 
have not explicitly modeled the effects of posttreatment environmental variables (such as aftercare 
services, use of self-help groups, and support for sobriety from family and friends) on treatment out- 
comes over time. In this study, the extant literature is moved forward by using growth models to 
examine the moderating effects of personal characteristics and the mediating effects of  proximal 
outcomes on the relation of treatment and changes in use of alcohol. The theoretical model of  Finney 
and Moos ~9" 2~. 24 was used to develop the growth models tested in this study. This model (Figure 1) 
hypothesizes that prior individual characteristics will moderate the effects of SMI-SD inpatient 
treatment on longitudinal community outcomes. It also hypothesizes that proximal treatment out- 
comes (e.g., motivation for sobriety) and posttreatment environmental characteristics are interven- 
ing variables in the causal processes that occur between treatment and observations of  long-term out- 
comes. Consumers' differential posttreatment functioning may be associated with differences in 
their immediate treatment outcomes (e.g., their motivation for sobriety) and their posttreatment 
environments (e.g., rehospitalization, use of community based treatments, self-help attendance, or 
social support for sobriety). 
The individual characteristics of people diagnosed with SMI-SD describe them as younger, more 
often male, less compliant with treatment, and engaged in more violent or criminal behavior than 
persons with only a diagnosis of mental illness) T M  However, conflicting results are reported for com- 
munity functioning, substances of choice, and the role of personal characteristics in treatment of  per- 
sons with SMI-SD) 2'~7"~1 The conflicting results of previous studies regarding the role of gender, age, 
ethnicity, diagnosis, and treatment history suggest that one or more of these variables may moderate 
the effects of  treatment. 
Posttreatment environmental characteristics are another set of  variables that may influence 
posttreatment outcomes. These variables cover a broad range of community-living experiences, 
work, social support, formal treatment alternatives (e.g., community-based mental health and sub- 
stance use services), and informal treatment in the form of self-help organizations and groups.S' 29 In 
this study, incarceration and rehospitalization were used as indicators of restrictions in the 
posttreatment environment that may reduce access and use of  substances) 9 
Self-help interventions using 12-step or Alcoholics Anonymous (AA) models are now consid- 
ered a core component of integrated treatment programs for persons with SMI-SD. ~34 There is evi- 
dence that a strength of integrated treatment programs is their preparation of patients to successfully 
participate in self-help groups.~9'3° The literature on AA outcomes for persons without mental illness 
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Figure 1 
Theoretical Model of Treatment, Prior, Intervening, and Outcome Variables 
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suggests that 12-step groups can play a significant role in the recovery from substance use problems. 
These groups provide environmental and social supports for recovery and abstinence. Johnsen and 
Herringer 35 found that attendance at AA or Narcotics Anonymous (NA) meetings was significantly 
related to posttreatment abstinence, whereas other social factors did not independently predict absti- 
nence. Finney et al. 19 suggest that the addition of 12-step support groups to outpatient aftercare ser- 
vices may result in improved long-term outcomes because the types of proximal treatment outcomes 
produced by 12-step models support sobriety. Drake et al.~8. 36 have noted the need to motivate per- 
sons with SMI-SD to participate in 12-step type groups. The support provided by self-help groups is 
critical for persons with SMI-SD who may lack the social skills needed to replace substance-using 
peers with sober peers, have difficulty structuring their time and activities, 3~ and need the same type 
of support and benefits begun in formal treatment programs/3 
The posttreatment environment domain also includes a variety of social resources, such as gen- 
eral social support from family and social network members and support for staying sober from net- 
work members.3" 33, 37 These resources can provide significant support and reinforcement to individual 
commitment to change to a healthier lifestyle and resist relapse.3"33'37"3s The person's family and social 
network play critical roles in supporting and reinforcing reductions in the use of alcohol and drugs? 8 
Studies in the alcohol field have identified positive association between social support and reduction 
of alcohol-related problems. 39' 4o Furthermore, epidemiological studies have shown that for persons 
with any mental or addictive disorder, a large proportion (37%) of requests for help are to support 
networks composed of friends, relatives, and self-help groups. 4~ 
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Motivation for change is a pivotal variable and a key proximal outcome for dual treatment pro- 
grams. ~ The literature on alcohol treatment suggests that motivation for change is a key variable in 
whether treatment is effective. 42 Finney et al) 9 compared motivational and belief variables for per- 
sons in programs using 12-step models to persons in programs using cognitive-behavioral models 
and found significantly greater change in motivation for programs using 12-step-type models. 
Finney et al. argue that in 12-step-type programs, changes in motivation are the proximal outcomes. 
Research on processes of change for both persons with serious mental illness and persons with sub- 
stance abuse disorder has often emphasized the importance of motivation for change and treatment 
goals.43 The theory on which most specialized SMI-SD programs are based also argues that changing 
the person's motivation to refrain from using substances is an immediate outcome of treatment and a 
prerequisite for preventing relapse. "44''5 Thus, the attitudes that persons with SMI-SD diagnoses hold 
about mental illness, substance abuse, and addiction at the conclusion of formal treatment should 
play an important role in their patterns of community functioning. Drake et al. 18' 36 noted in their 
conclusions that motivational interventions are necessary to prepare persons with SMI-SD for absti- 
nence-oriented interventions. Motivation, however, is a little-examined dimension in research on 
persons with SMI-SD but should influence posttreatment outcomes. 
In this study, the impact of an inpatient-integrated mental health and substance use treatment pro- 
gram was assessed by comparing the days of alcohol use over 18 months by persons who received 
the dual treatment with those who did not. Previous analyses of outcomes at discharge (proximal 
outcomes) had indicated that persons receiving SMI-SD treatment were more motivated to stay 
sober and to go to self-help groups after discharge. ~ The effects of the latter factors were explicitly 
modeled on growth curves models of individual change over time accounting for the treatment 
received and other covariates. 
Method 
Procedures 
Sample recruitment occurred over a 12-month period during which all persons newly admitted to 
the hospital were screened to identify those who met criteria for mental illness and substance abuse. 
Eligibility required a positive screening for alcohol or drugs (based on the 28-item Michigan Alco- 
holism Test 47 modified to include alcohol and drug use), clinical determination of substance abuse 
problems, and willingness of the consumer to accept admission to the Mental Health Chemical 
Dependence (MHCD) program. Persons who displayed unmanageable behavior requiring extensive 
seclusion and restraint were excluded (estimated to be 10% of those eligible). During recruitment, 
both treatment programs were described to the person along with the purpose and procedures of  the 
study. Informed consent was obtained from each participant prior to treatment assignment. Assign- 
ment to treatment condition was randomized within gender and order of enrollment with a ratio of 
2:1 assignment to the MHCD program (experimental) to the standard short-term treatment wards 
(STW) (control). Participants were interviewed during their first week in the study, 4 weeks later or 
at discharge (whichever occurred first), and at 2, 6, 10, 14, and 18 months postdischarge by inter- 
viewers hired by the research project. The study sample contained 485 members. Retention rates for 
follow-up interviews at 2, 6, 10, 14, and 18 months were, respectively, 86.7%, 85.6%, 85.1%, 84.5%, 
and 88.4%.4~ Of the 485 sample members, 429 had at least one postdischarge interview, with 76% 
having all five postdischarge interviews. Analyses presented here are based on these 429 
participants. 
Setting 
The study was conducted at a JCAHO-accredited state psychiatric hospital serving a large urban 
catchment area in the Midwest. The hospital's MHCD program provided specialized, coeducational 
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treatment on two 30-bed wards that had a 3:2 ratio of male to female beds and served as the experi- 
mental condition. STWs were used as the control condition. The MHCD program had mental health 
staff trained in substance abuse treatment and had a 1:6 staff-to-patient ratio. STW mental health 
staff were not trained in substance abuse treatment, and these wards had 1:8 staff-to-patient ratio. 
The MHCD program was based on a staged theoretical model, z4, ~8.u.~ These stages of treatment 
may overlap and are not necessarily sequential for each individual. Stage lwas the stabilization of 
acute psychiatric and physical symptoms for both the STW and MHCD programs and included med- 
ical and psychiatric assessment and screening for substance abuse. Stage 2 engaged the consumer in 
the treatment process using individual, group, and activity therapy. Additionally, the MHCD pro- 
gram provided educational lectures, AA and/or NA groups, family education sessions, and gen- 
der-specific support groups to engage participants. The MHCD program focused on persuasion and 
awareness in stage 3 through the use of 40 formal educational lectures that covered the disease con- 
cept of addiction, physiological effects of drugs, HIV/AIDS prevention health issues, recovery and 
relapse, and mental illness concepts and treatment issues. The lectures were intended to provide 
information, change consumers' attitudes about substance use, and increase motivation for program 
involvement and recovery. The STW program had no similar treatment component. Stage 4 involved 
active treatment through individual and group psychotherapy and activity therapy for both condi- 
tions. The MHCD program provided a minimum of one hour per week of individual therapy and one 
hour per day (five hours per week) of group therapy compared with a half hour per week of individual 
and one hour per week of group therapy in STW. The MHCD mental health treatment also addressed 
drug and alcohol addiction problems, and therapy was focused on reducing denial, enhancing coping 
skills, and improving interpersonal relationships. Furthermore, the MHCD program required atten- 
dance at two AA and/or NA meetings per week, while the STW did not emphasize substance use 
treatment although consumers could elect to attend AA and/or NA meetings. Finally, stage 5 focused 
on relapse prevention through the discharge-planning process and was similar for both groups. The 
MHCD program additionally emphasized strategies for remaining clean and sober and identified 
AA and NA groups in the community to which the consumer was returning. 
The MHCD group stayed, on average, 20 days longer in the hospital than the STW group (51.4 
days vs. 31.1 days). Although the two groups were comparable on entry, difference in length of stay 
could produce differences in levels of behavior and attitudes on discharge. The multilevel models 
used to assess the treatment effect account for the treatment effect at two months postdischarge as 
well as treatment effect on rate of decline from admission to two months postdischarge. As a rate, 
this latter effect is independent of the length of stay. At discharge, the MHCD group had greater 
knowledge of substance use issues and 12-step programs and expressed stronger motivation to con- 
trol their substance use, remain sober, and attend 12-step groups after hospitalization. ~ These vari- 
ables represent the proximal outcomes for treatment and provide some evidence that cross contami- 
nation of the experimental and control groups was not a major factor. 
Sample 
Descriptive variables for 429 participants are presented in Table 1. Participants were distributed 
similarly in MHCD and STW conditions. No significant differences between the groups were found 
at admission in demographics, previous treatment history, importance of treatment to the person, or 
functioning before hospitalization. The majority of participants were males in their mid-30s. 
Two-thirds of the sample had one or more prior psychiatric hospitalizations. Psychiatric and sub- 
stance use diagnoses also are presented in Table 1. Almost two-thirds of the participants had diagno- 
ses indicating serious mental illness (schizophrenia, organic mood disorders, major depression, or 
bipolar depression). Nearly three-quarters of the participants had diagnoses related to alcohol use. 
Diagnoses related to cocaine use were the most frequent nonalcohol drug use diagnoses. 
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Table 1 
Sample Characteristics (in percentages) 
Proportion male 73.9 
Ethnicity 





Mean age in years (SD) 33.2 (7.2) 
DSMIII-R diagnosis 
Mental illness 
Schizophrenic disorders 28.1 
Organic mood disorders 23.1 
Mild affective disorders 17.5 
Adjustment disorder 15.9 
Major depression 8.1 
Bipolar depression 5.3 
Antisocial personality 1.9 
Substance abuse a 
Alcohol dependence 47.3 
Alcohol abuse 26.1 
Cocaine dependence 39.9 
Cocaine abuse 20.3 
Cannabis dependence 10.3 
Cannabis abuse 12.4 
NOTE: N = 429. 
a. Multiple diagnoses were permitted. 
Analysis Model 
The Addiction Severity Index (ASI) 49s~ was used as the major data collection tool.* Scale scores 
for the ASI are constructed to range from 0 (no problem) to 1 (high problem level). However, the ASI 
metric is not clearly defined, nor are these scales necessarily interval level. These issues are of  con- 
cern whenever using the ASI in a statistical analysis. However, they are of  special concern when 
modeling change over time, as change must be based on an interval scale measure, n 
To address these concerns regarding the scale of the ASI, examinations were conducted of the dis- 
tribution of the ASI alcohol scores at each time point, as well as residuals from linear regression of 
the ASI regressed separately at each time point on variables to be used in the growth models. 
Although the ASI alcohol scores were approximately normally distributed on intake (reflecting its 
validity as a measure used for clinical diagnosis), the distributions became increasingly positively 
skewed with time (i.e., there were many subjects who scored on the lowest end and only a few who 
scored on the highest end, leaving a long positive tail). Consequently, the ASI is not an optimal mea- 
*Modifications to the Addiction Severity Index recommended by the authors for use with persons with serious mental ill- 
ness and substance use disorders were used? ~ In this study, internal consistency coefficients (average .70, range .56 to .86) 
were found that compared favorably to reliability figures for a dual diagnosis sample reported by Hodgins and E1-Guebaly. sl 
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sure for modeling change over time. In particular, at later time points, decreases on the lower end of 
the scale may be much more difficult to achieve than decreases on the higher end of  the scale. 
To address this concern, two modifications of  the ASI score were considered. First, the logit 
transformation (Log [ASI/(1 - ASI)]) was used to correct the skew. This improved the distribution of 
the residuals from each time point somewhat. When the logit of ASI alcohol scores was modeled, the 
substantive interpretations were the same as those based on the analyses to be reported here. 
The second approach was to deconstruct the ASI alcohol score and focus the analysis on the num- 
ber of  days of alcohol use in the month prior to each interview. This outcome is a count, and conse- 
quently a Poisson sampling model with a log-link function was used at level 1 of the analysis (the 
Poisson sampling model is intended for counts and can accommodate skewed distributions in which 
many people have low counts).* The number of days of alcohol use also provides a behaviorally 
based measure with an easily understood metric and is an interval scale (e.g., the difference between 
1 and 5 is the same as the difference between 21 and 25; both are a change of 4 units). The results 
from this analysis are reported here. The parameters of this latter analysis are easier to interpret, rep- 
resenting the effect on the number of days of  alcohol use in the past 30 days. 
Building the model for change in days of alcohol use over time began by considering a standard 
regression model for days of alcohol use (DAU) at time t as a function of time: 
Log (DAU,) = 130 + ~ltimet. (I)  
Time was measured as months relative to discharge, which accommodated the fact that different 
people were measured at different intervals and that different people were placed in the program at 
different times of the year. The effect of time may have been different during the period of the treat- 
ment than during the extended posttreatment period. In particular, since the participants were in cri- 
ses when they entered the treatment, and since both treatment and control involved hospitalization, 
the most dramatic decrease in days of  alcohol use might be expected to occur during the interval right 
around treatment. Visual examination of the data supported this expectation (Figure 2). Therefore, 
the effect of time was separated into two pieces: 
Log (DAUt) = 130 + ~ltime from admission to 2 months 
postdischarge t + ~2time 2 months postdischarge through end of study,. (2) 
Here, l~l represents the effects of  time in the first interval, and 132 represents the effects of time in 
the second interval. 
In this model, time points were nested within people, and the effects of people must be accounted 
for in the model. Consequently, the assumption made for statistical inference that the error terms 
were independent was not likely to be satisfied, because any two error terms associated with the 
same person were likely to be positively correlated (see Bryk and Raudenbush, chap. 6s3). To address 
the nested nature of the data, the model (equation 2) was extended to a multilevel framework: 
At level 1 (time points): Log (DAUIt) = 13oi + 131~ time from admission to 2 months 
postdischarg% + 
~21time 2 months postdischarge through end of studyit. 
*The log-rink function is used to ensure that predictions are constrained to be within a given interval; for example, in this 
analysis, the event rate is constrained to be nonnegative because it is a count. The log of the event rate can take any real value 
(negative or positive), while the event rate can only be nonnegative. Thus, the predicted values for this analysis are predicted 
log-event rates in which a negative value indicates a decline and a positive value indicates an increase in the event rate. The 
log-event rate can be converted to event rates by computing: event rate = exponential (n,j), where n~ = log of the event rate. 
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Figure 2 
Mean Days of Alcohol Use Reported at 
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And at level 2 (people): ~Joi = yoo + l.toi, 
~ = 71o + lx~i, and 
112~ = 720 + lx2i. (3) 
At level 1, each variable has been subscripted to represent the observation for person i at time t. 
This represents the nested nature of the data. The parameters 1]o~, ~,i, and []2~ each are assigned sub- 
scripts i indicating that they are uniquely estimated for each person i. Then, at level 2, each parameter 
is modeled as a function of  the overall effect (Too, 71o, and Y20, respectively), as well as an error term 
(~t~, lX~, and Ix2,, respectively). It is these error terms that capture and account for the unique effects of  
each person on the intercept and growth parameters. ~~ 
Treatment was implemented at the level of  the participant (e.g., each person either received or did 
not receive the treatment), and, therefore, the treatment effect is modeled at level 2: 
[~ol = 700 + T01 treatmenti + I.toi, 
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131i = Yl0 + Tn treatment," + ~t~i, and 
132i = ) '20 + )'21 treatment/+ l-t2~ • (4) 
The effect of the treatment on the intercept is captured by )'0~, the effect on the change during the first 
time interval by YH, and the change on the second time interval by Y2~. 
The advantage of the multilevel framework is that it accounts for unbalanced and incomplete data 
in estimating the parameters. For example, during the second time interval, some subjects were mea- 
sured at as many as five time points four months apart, while other subjects were measured at three 
time points at unequal intervals. Rather than deleting data or modifying the time intervals as would 
be required by a traditional repeated measures ANOVA, the multilevel model uses all of the data in 
their original form. The key is that the model is specified as a function of time, and the estimation 
essentially weights for the number of observations per person, so those people who were measured 
less frequently contribute less to the overall estimates. 
An alternate way of appreciating the advantage of the multilevel model is to observe that the 
sources of error in the models are at level 2 (kt0i, lxli, and kt~i). This allows the treatment effect, which 
was defined at level 2, to be assessed relative to the variability in the errors at level 2. These level 2 
errors are more likely to be independent than the error in a single-level model (such as equation 2) 
because the level 2 errors (in equation 4) represented differences between people. Thus, the effect of 
level 2 predictors (such as treatment) can be reported in terms of variation explained at level 2 of the 
model. Furthermore, it recognized that the degrees of freedom used as a basis for assessing the treat- 
ment effect should be based on the number of subjects, not the total number of observations. Thus, 
the standard errors for the treatment effect reflect the level at which the treatment was implemented. 
This, in turn, reduces the artificial deflation in the standard error term caused by multiple time points. 
The multilevel framework can easily accommodate covariates that vary with respect to time (such 
as whether a person was incarcerated during the month prior to each interview) by incorporating 
them into the level 1 model. Covariates that are invariant with respect to time (such as whether a per- 
son was diagnosed with alcohol dependence or abuse) are incorporated into level 2 of the model. The 
multilevel model can also account for the effects of level 2 predictors on any level 1 effect. For exam- 
ple, the model can specify the effect of an alcoholism diagnosis on the rate of change in days of alco- 
hol use during the first time interval. In this way, the multilevel model accounts for all of  the factors 
of the traditional split-plot and repeated measure designs while allowing for more flexible model 
specification and estimation based on unbalanced data. 
The final multilevel model for days of alcohol use for person i and time t was the following: 
At level 1: Log (DAU/,) = ~ol + ~li time from admittance to 2 months 
postdischarg% + 
132; time 2 months postdischarge through end of studyit + 
[~3; participation in self-helpi t + 134; incarcerationit + 
135; support for sobriety;t, 
And at level 2: 130i ~-~ )'00 + ~01 treatment; + )'o2 schizophrenia diagnosis; + 
%3 alcohol diagnosisi + )'o4 intentions to stay sober; + 
%5 family involvement in treatment; + kt~, 
131i = )'1o + )'11 treatment; + )'12 intentions to go to self-helpi + 
)'13 family involvement in treatment~ + I.tn, 
13zi = )'20 + )'21 family involvement in treatment i + lxzi, 
133; = )'30 + )'31 intentions to stay sober;, 
134; = )'40 + )'41gender~ + )'42alcohol diagnosis; + Ya3intentions 
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to stay soberi, 
[isi = Yso + Y51treatmenti + Y52alcohol diagnosisi + y53family 
involvement in treatments. (5) 
At level 2, each level 1 parameter is modeled as a function of individual characteristics (diagno- 
sis, gender, family involvement), the proximal treatment outcomes (motivation), and/or 
posttreatment environmental characteristics (self-help use, incarceration, and social support for 
sobriety). In this case, we observe that the intercept 13, is a function of treatment, schizophrenia diag- 
nosis, diagnosis of alcohol abuse or dependence, intentions to stay sober, and family involvement in 
treatment. 
The intercept in the level 1 model, ~ol, was defined to represent the person's days of alcohol use at 
two months after discharge from the treatment or control condition, thus allowing differences in the 
treatment and control groups at two months postdischarge to be identified (see Bryk and 
Raudenbush, 53 pages 25-29, for a discussion of centering; centering has no effect on the interpreta- 
tion of the other regression coefficients, [~x~, ~2i, 13~,i, and [~4i, only on ~ ) .  Nonrandomly, time varying 
covariates have been included to indicate whether the person participated in a self-help process (such 
as AA), was incarcerated during the 30 days previous to the interview, and the amount of support for 
sobriety the person reported. The effects of the latter three covariates are fixed across people and do 
not have an error term specified at level 2 (there is no ~t~, ~t~, ~ts~). 
The model was tested in the hierarchical generalized linear model (HGLM) routine of  Bryk, 
Raudenbush, and Congdon: 6 A Poisson sampling model was used with a log link function, which is 
appropriate for count data. Equal exposure or opportunity for occurrence (number of days) was spec- 
ified. The first step in testing this model was to establish the unconditional model, which is the level 1 
model with only the time variables included (e.g., with no level 2 predictors or other level 1 predic- 
tors, equation 3). Other level 1 predictors were tested in the model using a step-up strategy guided by 
the theoretical model:  3 Once all level 1 predictors had been entered, level 2 predictors were entered. 
Again, a step-up strategy guided by the theoretical model was used with treatment condition tested 
first, followed by individual characteristic variables, the proximal treatment outcome variables, and 
then the posttreatment environmental variables. 
Measures 
Days of alcohol use was collected in the alcohol and drug section of the ASI and reflected the 
number of days the participant reported consuming any alcohol (Table 2). Time was measured in 
months from the first community interview at two months postdischarge to previous (admission) 
interview and to each subsequent community interviews: 3 Thus, the base time point in the model 
applies to two months postdischarge. Data on use of informal self-help groups (e.g., AA and/or NA) 
in the past 30 days were collected as self-reports in the interviews (0 = no attendance, 1 = had 
attended). Incarceration in the past 30 days was based on self-reports provided as part of the ASI 
interview (0 = no, 1 = yes). Support for sobriety was asked during enumeration of participants' social 
networks. Participants were asked how much help each social network member gave them in staying 
clean (1 = not at all, 5 = extremely). Mean level of support was calculated across all members of the 
social network for each participant. Family involvement in treatment was coded based on hospital 
records to indicate level of involvement by family members during the inpatient treatment (1 = not 
involved, 2 = moderately involved, 3 = involved). Treatment group was coded 0 for STW (control) 
and 1 for MHCD (experimental). Diagnosis of schizophrenia (0 = no, 1 = yes), diagnosis of alcohol 
dependence or abuse (0 = no, 1 = yes), and gender (0 = female, 1 = male) were also coded as dichoto- 
mous variables. Final psychiatric and substance use diagnoses assigned prior to discharge were col- 
lected from hospital clinical records and used to create the three diagnosis variables. Two measures 
of motivation were assessed at discharge. A two-item scale assessed future intentions to stay sober (1 = 
no intentions, 4 = strong intention; ¢x = .81). The second variable was also from the discharge inter- 





























































































































































































































































































































































































































































































































































































































































































































view and asked participants how strong their intentions were to attend self-help groups (1 = no inten- 
tions, 4 = strong intention). ~ 
Other level 1 and level 2 covariates were considered, but none reached the traditional significance 
level ofp < .05. These were psychiatric hospitalization during the 30 days prior to each interview (0 = 
no, 1 = yes), diagnosis of drug dependence or abuse (0 = no, 1 = yes), prior psychiatric hospitaliza- 
tion history (0 = none, 1 = 1 or more), age at admission, and race/ethnicity (0 = white, 1 = African 
American). 
Results 
The population-average model results, which indicate how a change in the predictor can be 
expected to affect the overall population mean, are presented in Table 3. Table 3 presents 13 and e ,  
which is the event rate or the estimated number of events (days of alcohol use) during time interval. 
Negative 13s indicate declines in event rates, and positive ~s indicate increases in the event rate. The 
base days of alcohol use at two months postdischarge (23o0) was e 1'55 or estimated at 4.71. Treatment 
(23ol) reduced the base rate of alcohol use (e '61), controlling for other variables in the model (p < .001). 
In other words, for someone who did not receive the integrated treatment, the expected rate of  alco- 
hol use was 4.71 days per month. The expected rate was 4.71 × .54 = 2.54, if the person received the 
integrated treatment. This constitutes a 54% reduction in days of use if the person participated in the 
treatment. Having a diagnosis of schizophrenia (23c~) was negatively related to the rate of alcohol use 
(e"67). However, those with an alcohol dependence or abuse diagnosis (23o3) had a higher rate of  alco- 
hol use (e~ "). Stronger intentions to stay sober (2304, measured at discharge) reduced the rate of use 
(e°26). Although not reaching a traditional significant level ofp < .05, family involvement in inpatient 
treatment (23o5) also reduced the rate of alcohol use (e"15). 
What these finding indicate is that the rate of alcohol use at two months postdischarge depended 
on a number of variables. To calculate the effect of parameters on the rate of use, the coefficients are 
exponentiated (e a) and these values multiplied by the base rate. For example, people with diagnoses 
of alcoholism who were in the STW group, had low intentions, and no family involvement had the 
highest rates of use, averaging 14.6 days per month (4.71 x 3.10 = 14.6; all other parameters have 0 
values and drop out of the equation). Similar persons in the MHCD program had an average rate of 
7.88 (4.71 x 3.10 x .54 = 7.88). Thus, the treatment effect for persons with diagnosis of alcoholism 
and a mental illness other than schizophrenia was to reduce the rate of alcohol use by 6.72 days per 
month. Among persons with diagnoses of alcoholism, those who also had diagnoses of schizophre- 
nia, received the MHCD treatment, had strong intentions to stay sober, and had high levels of family 
involvement had a lower rate of 2.66 days of use per month (4.71 x 3.10 × .54 × .51 x .77 x .86 = 
2.66). Among persons without diagnoses of alcoholism, those in the MHCD program had lower 
rates of use, 2.54 days per month (4.71 x .54 = 2.54). The addition of the other characteristics further 
reduced the rate of use for this latter group to an average of.86 days per month (4.71 x .54 x.51 x .77 × 
.86 = .86). 
In the first time period, the rate of alcohol use declined from admission to two months after dis- 
charge by .74 days per month. MHCD treatment further accelerated the decline in the rate of  use, as 
did strong intentions to go to self-help and high levels of family involvement in treatment. In the sec- 
ond time period, the rate of change in days of alcohol use from two months postdischarge through the 
duration of the study was estimated at 1.01 days. This rate of change did not reach the traditional 
level for statistical significance (p < .05). Note that there was no effect of treatment on the rate of 
change in days of alcohol use after two months postdischarge but that the rate remained relatively 
stable, as do the differences between the groups. 
Three additional time-varying predictors affected the changes in the rate of alcohol use. The rate 
of alcohol use at any given time point was less for persons who had attended meetings of a self-help 
group during the previous month. Strong intentions at discharge to stay sober (2331) offset the effect of  
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Table 3 
Results of Hierarchical Linear Modeling (population average model) 
Coefficient 6 Standard T p 
Fixed Effects (e ~) Error Ratio Value 
Intercept for 6o 
Mean days used alcohol at 2 months 
postdischarge 1300 1.55 (4.71) .08 19.88 .0001 
Treatment effect 6o~ -.61 (0.54) .15 --4.05 .0001 
Schizophrenia diagnosis 6o2 -.67 (0.51) .14 -4.82 .0001 
Alcoholism diagnosis [3o3 1.13 (3.10) .13 8.45 .0001 
Intentions to stay sober 604 -.26 (0.77) .12 -2.17 .03 
Family involvement in treatment 60~ -.15 (0.86) .10 -1.55 .12 
Slope for 2 months postdischarge to admission 61 
Intercept 6~0 -.30 (0.74) .02 -12.73 .001 
Treatment effect 611 -.10 (0.90) .05 -2.18 .03 
Intentions to go to self-help 612 -.09 (0.91) .03 -3.01 .003 
Family involvement in treatment 13~3 -.06 (0.94) .03 -2.18 .03 
Slope for 2 months to 18 months postdischarge 62 
Intercept 132o .01 (1.01) .01 1.81 .07 
Family involvement in treatment 62~ .01 (t.01) .01 1.87 .06 
Slope for self-help attendance 63 
Intercept 630 -.33 (0.72) .03 -11.59 .0001 
Intentions to stay sober 631 .22 (1.25) .05 4.85 .0001 
Slope for incarceration 64 
Intercept 64o -.55 (0.58) .07 -7.93 .0001 
Gender 1341 -.78 (0.46) .11 -6.89 .0001 
Alcoholism diagnosis 642 .49 (1.63) .19 2.54 .01 
Intentions to stay sober [~43 .43 (0.65) .09 -4.96 .0001 
Slope for support for sobriety 
Intercept 650 -.09 (0.91) .01 -8.23 .0001 
Treatment effect 135~ .07 (1.07) .02 4.36 .0001 
Alcoholism diagnosis 652 -.10 (0.90) .03 -3.45 .001 
Family involvement in treatment 653 -.04 (0.96) .01 -4.00 .0001 
attendance at self-help groups on the rate of alcohol use, indicating that for those persons with initial 
strong intentions to stay sober, self-help attendance had less effect on their use of alcohol. Incarcera- 
tion in the month prior to the interview (Y4o) also lowered the rate of alcohol use. Gender (being 
female) enhanced the effect of incarceration, as did strong intentions to go to self-help. However, a 
diagnosis of alcohol dependence or abuse reduced the effect of incarceration on the rate of alcohol 
use. Support for sobriety further reduced the rate of alcohol use. The effect of support for sobriety 
was enhanced for participants with an alcohol dependence or abuse diagnosis (352) and for partici- 
pants with higher levels of family involvement in inpatient treatment (Y53)- Membership in the exper- 
imental group offset the effect of support for sobriety (Ys~). This indicates that receiving the dual 
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treatment for mental illness and substance use reduced the observed impact of social network sup- 
port for sobriety. In other words, treatment overcame the lack of social support for sobriety. The final 
model accounted for 18.8% of the variance in the intercept when the final level 1 model with level 2 
predictors was compared to the final level 1 model without level 2 predictors. 
Discussion 
The theoretical model for dual diagnosis treatment suggested that the treatment effects would be 
influenced by individual characteristics, the proximal treatment outcomes, and what happens when 
the individual returns to the community in terms of social support and use of formal and informal ser- 
vices. In this study, differential longitudinal outcomes were affected by variables suggested by the 
theoretical model. 23'2~ Participants' use of alcohol was determined, in part, by their diagnoses, imme- 
diate treatment outcomes (intentions), social support, and incarceration. Status on each of these vari- 
ables was associated with increases or decreases in the number of days on which alcohol was used. 
The long-term effects of treatment were not uniform. Failure to consider the effects of specific indi- 
vidual characteristics (such as diagnosis), whether treatment produced the desired immediate 
changes in the individual, and posttreatment experiences may be responsible for the lack of treat- 
ment effects in other studies. 
The proximal outcome of treatment--motivation for change--was an important covariate. Per- 
sons in the MHCD program reported significantly stronger intentions to remain sober and attend 
self-help groups when they returned to the community. 46 Stronger intentions at discharge to stay 
sober predicted lower rates of alcohol use at two months postdischarge, and intentions to attend 
self-help groups predicted greater rates of change from admission to two months postdischarge. 
These findings suggested that the MHCD program prepared participants to deal with their substance 
use problems. It helped participants to be ready to change. Those participants who received the dual 
treatment and reached the critical point of change, indicated by their strong intentions to stay sober, 
reduced their alcohol consumption more than those who did not receive the treatment regardless of 
their 16~vel of intentions. 
The findings also point out the potential for posttreatment experiences to affect the observed out- 
comes. Self-help attendance reduced the rate of alcohol use. It was particularly effective when moti- 
vation to stay sober was low, such as was the case for the control group. Incarceration also resulted in 
fewer days of alcohol use. Number of days incarcerated was not collected, and this limits explana- 
tions as to why incarceration resulted in fewer days of alcohol use. It is possible that incarceration 
reduced the number of days during which alcohol could be accessed and this resulted in artificially 
low scores. Greater family involvement while the individual was hospitalized was associated with 
stronger levels of support for sobriety and magnified the effect of such support in decreasing alcohol 
use. However, treatment in the MHCD program nearly offset the effect of such support. In contrast, 
social support for sobriety was important to reducing the rate of use for those in the control condi- 
tion. Again, this suggests that the MHCD program affected some change intrinsic to the person. In 
the absence of such a change, an external force, such as self-help attendance or social support for 
sobriety, was needed to reduce alcohol use. 
Limitations 
As in other studies of this type, this one has limitations due to methodology and resource con- 
straints. The outcome measure is based on self-reports and suffers from the biases inherent in all 
self-reports. Corroboration from another source, whether biochemical, clinical ratings, proxy 
reports, or another instrument, x3 would strengthen confidence in the level of alcohol use by partici- 
pants. Self-selection to attend self-help posthospitalization is another potential limiting factor. The 
current study did not have the means to determine whether attenders were different from 
nonattenders in important but unmeasured ways. This is an underdeveloped area within SMI-SD 
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treatment that warrants greater investigation. Additionally, the measure of self-help attendance used 
in this study is weak and did not permit the quality of participation to be assessed. However, the study 
does point to a potentially powerful community asset--mutual supportnfor persons with serious 
mental illness and substance use. 
Implications for Behavioral Health Services 
The value of an inpatient program that simultaneously treats both serious mental illness and sub- 
stance use is its ability to give the consumer a safe, structured environment in which education, coun- 
seling, and participation in self-help can lead to changes in motivation to deal with the substance use 
problem. The results of this study indicated that dual diagnosis programs are valuable and can estab- 
lish a basis for long-term change and improved community functioning. The study showed that sup- 
port for sobriety is important to long-term outcomes and that the treatment effects for such programs 
can overcome lack of support for sobriety. One means of providing such support appears to be 
through self-help groups, such as AA. Although much of the literature on dual treatment programs 
identifies families and social networks as key to posttreatment sobriety, 3' 37.3~ 57 their roles in ongoing 
aftercare treatment have not been emphasized. The results of this study point to the need for ongoing 
careful assessment of the characteristics of the individual's environment and social resources as part 
of effective mental health care. 
The findings of this study suggest that as mental health systems move to managed care packages, 
inpatient treatment programs for substance use and serious mental illness can be a valuable compo- 
nent. These programs should not be treated, however, as a separate component in an array but as a 
first step in a treatment process? 8 The treatment process should include assessments of the individ- 
ual's motivation to change and willingness to continue with behaviors, such as attending AA, that are 
established while in the hospital. The treatment process should develop with the consumer clear 
plans for achieving his or her goals after leaving the hospital, including the use of formal services and 
self-help groups, and emphasize individual planning? g It is important for the treatment process to 
help the consumer develop links with community self-help groups. Early connection with commu- 
nity groups should be initiated while the consumer is still in the integrated treatment program and 
should focus on developing a relationship with a sponsor. Postdischarge support for self-help atten- 
dance should be part of the aftercare provided. 
The posthospitalization treatment process should support and encourage attendance at self-help 
groups and continue to monitor, with the consumer, his or her motivation to stay sober and psycho- 
logically healthy. Maintaining the individual's motivation will require different strategies than have 
traditionally been used for aftercare services. Assessment with the consumer of his or her environ- 
ment, social network/support system, and community for ongoing support and threats to sobriety 
will be essential. Mental health services should focus therapeutic efforts on helping consumers to 
gain skills in managing their mental illness, maintaining sobriety, and achieving goals through flexi- 
ble, accessible, personalized services? 8 Although person-centered approaches are not the general 
practice, a focus on the goals of the person throughout the treatment process will help develop the 
internal motivation to maintain gains in sobriety achieved through integrated treatment programs. 
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